PRIMARY STUDY

Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a Review

Key Findings:  The authors conclude that THC and CBD have shown neuroprotective properties with relevance to patients with AD and PD. However, the team also warns of potential adverse effects.

Type of Study:  Meta-analysis

Study Result:  Positive


Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC)

Phytocannabinoid Source:  Not Applicable

Form of Administration:  Not Applicable


Study Location(s):  Australia

Year of Pub:  2020


Link to study